Hemangiomas can present a difficult problem in management. Much controversy exists over whether it is better to watch and wait for natural involution or to be more aggressive and attempt to prevent some of the potential negative sequelae. Different modalities have been employed in the treatment of hemangiomas, including systemic therapy – antiangiogenic drugs, i.e. systemic corticosteroids and α-interferon – and local therapy – surgical procedures, arterial embolization and cryotherapy. Overall, a very conservative approach to therapy has been recommended because of treatment risks, treatment inadequacy and lack of evidence showing superiority over natural involution. Recently laser treatment has been used in the therapeutic approach of hemangiomas. This review discusses the pros and contras of early laser treatment of hemangiomas. For superficial hemangiomas, the flashlamp pumped pulsed dye laser in particular has proven itself in numerous studies. In the treatment of hemangiomas with subcutaneous components, the Nd:YAG laser is the treatment of choice.

Keywords:
Hemangioma, Laser treatment, Laser types, Flashlamp pumped pulsed dye laser
1.
Glassberg E, Lask G, Rabinowitz LG, Tunnessen WW: Capillary hemangiomas: Case study of a novel laser treatment and a review of therapeutic options. J Dermatol Surg Oncol 1989;15:1214–1223.
2.
Frieden IJ: Which hemangiomas to treat – and how? Arch Dermatol 1997;133:1593–1595.
3.
Landthaler M, Haina D, Brunner R, Waidelich W, Braun-Falco O: Neodymium-YAG laser therapy for vascular lesions. J Am Acad Dermatol 1986;14:107–117.
4.
Greve B, Raulin C: Der Nd:YAG-Laser im Wandel der (Impuls-)Zeiten: Einsatzgebiete in der Dermatologie. Hautarzt 2000;51:152–158.
5.
Landthaler M, Hohenleutner U, El-Raheem TA: Laser therapy of childhood hemangiomas. Br J Dermatol 1995;133:275–281.
6.
Poetke M, Philipp C, Berlien HP: Flashlamp pumped pulsed dye laser for hemangiomas in infancy: Treatment of superficial vs. mixed hemangiomas. Arch Dermatol 2000;136:628–632.
7.
Raulin C, Raulin SJ, Helwig S, Schonermark MP: Treatment of benign venous malformations with an intense pulsed light source (PhotoDerm VL). Eur J Dermatol 1997;1:219.
8.
Angermeier MC: Treatment of facial vascular lesions with intense pulsed light. J Cutan Laser Ther 1999;1:95–100.
9.
Raulin C, Greve B: Retrospective clinical comparison of hemangioma treatment by flashlamp pumped (585 nm) and frequency-doubled Nd:YAG (532 nm) lasers. Lasers Surg Med 2001;28:40–43.
10.
Levine VL, Geronemus RG: Adverse effects associated with the 577 nm and 585 nm pulsed dye laser in the treatment of cutaneous vascular lesions: A study of 500 patients. J Am Acad Dermatol 1995;32:613–617.
11.
Dinehart SM, Kincannon J, Geronemus R: Hemangiomas: Evaluation and treatment. Dermatol Surg 2001;27:475–485.
12.
Barlow RJ, Walker NJ, Markey AG: Treatment of proliferative hemangiomas with the 585-nm pulsed dye laser. Br J Dermatol 1996;134:700–704.
13.
Ashinoff R, Geronemus RG: Capillary hemangiomas and treatment with the flashlamp pulsed dye laser. Arch Dermatol 1991;127:202–205.
14.
Hohenleutner S, Ganter EB, Landthaler M, Hohenleutner U: Long term results in the treatment of childhood hemangioma with the flashlamp pumped pulsed dye laser: An evaluation of 617 cases. Lasers Surg Med 2001;28:273–277.
15.
Sherwood KA, Tan OT: Treatment of capillary hemangioma with the flashlamp pumped-dye laser. J Am Acad Dermatol 1990;22:136–137.
16.
Ricci RM, Finley EM, Grimwood RE: Treatment of cutaneous hemangiomas in preterm neonatal twins with the flashlamp-pumped pulsed dye laser. Lasers Surg Med 1998;22:10–13.
17.
Kim HJ, Colombo M, Frieden IJ: Ulcerated hemangiomas: Clinical characteristics and response to therapy. J Am Acad Dermatol 2001;44:962–972.
18.
Garden JM, Bakus AD, Paller AS: Treatment of cutaneous hemangiomas by the flashlamp pumped-dye laser: Prospective analysis. J Pediatr 1992;120:555–560.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.